Activation of Cytosolic Phospholipase A2 by Opsonized Zymosan in Human Neutrophils Requires Both ERK and p38 Map-Kinase
- 4 Citations
- 374 Downloads
1. Summary
The present study demonstrates that stimulation of human neutrophils with opsonized zymosan (OZ), which binds to Fc gamma receptors (FcãRs) and C3b receptors, activates both ERK and p38 MAP-kinase. Thus, the relative role of both types of MAP-kinase, ERK and p38, in activation of cPLA2 by OZ was studied. cPLA2 activation by OZ was detected 15 sec after stimulation, maintained a plateau for 10 min and decreased thereafter. p38 MAP-kinase activation exhibited kinetics similar to that of cPLA2, while ERK activation was detected within 15 sec but decreased significantly in less than 5 min after stimulation. Pretreatment of the cells with the MEK inhibitor, PD-098059, or the p38 MAP-kinase inhibitor, SB-203580 resulted in total inhibition of ERK or p38 MAP-kinase activity, respectively. Each inhibitor caused a partial inhibition during the time course of cPLA2 activity, while their combination caused a total inhibition. Compared to OZ, inactivated OZ, which does not contain the complement proteins, induced an identical time-dependent stimulation of ERK and p38 MAP-kinase as well as a similar cPLA2 activity, suggesting that the role of the C3b receptors in this system is negligible. It is concluded that OZ activates both ERK and p38 MAP-kinase and that the two isotypes are required for the onset and maintenance of cPLA2 activity.
Keywords
Human Neutrophil Superoxide Production Extracellular Regulate Kinase Cytosolic Phospholipase Opsonized ZymosanPreview
Unable to display preview. Download preview PDF.
References
- Borsch Haubold, A. G., Bartoli, F., Asselin, J., Dudler, T., Kramer, R. M., Apitz Castro, R., Watson, S. P., and Gelb, M. H., 1998, Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem 273: 4449–4458.PubMedCrossRefGoogle Scholar
- Dana, R., Leto, T. L., Malech, H. L., and Levy, R., 1998, Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273: 441–445.PubMedCrossRefGoogle Scholar
- Hazan, I., Dana, R., Granot, Y., and Levy, R., 1997, Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A2 and NADPH oxidase. Biochem. J. 326: 867–876.PubMedGoogle Scholar
- Lin, L. L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., and Davis, R. J., 1993, cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278.PubMedCrossRefGoogle Scholar
- Seger, R., and Krebs, E. G., 1995, The MAPK signaling cascade. Faseb J. 9: 726–735.PubMedGoogle Scholar
- Smith, J. A., 1994, Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56: 672–686.PubMedGoogle Scholar